Your browser does not support the NLM PubReader view.

Go to this page to see a list of supporting browsers.

Radiation Treatment for Prostate Cancer

Article information

J Korean Med Assoc. 2004;47(5):424-431
Publication date (electronic) : 2004 May 31
doi : https://doi.org/10.5124/jkma.2004.47.5.424
Jae Ho Cho, M.D.
Department of Radiation Oncology, Yonsei University College of Medicine, Severance Hospital, Korea. jjhmd@yumc.yonsei.ac.kr

Abstract

Selecting the optimal treatment of each stage of prostate cancer is very challenging, partly because the options for treatment today are far better than they were ten years ago, but also because not enough reliable data are available on which to base the decisions. Accordingly, scientifically controlled, long-term studies are still needed to compare the benefits and risks of the various treatments. In the process of counseling and discussing therapeutic options with patients with prostate cancer, it is important to present all available data regarding the variable natural history of this disease, prognostic significance of the diagnosis, potential therapeutic benefit of the various modalities, and immediate as well as late treatment-related sequelae. Radiation therapy can be given either as external beam radiation over perhaps 6 or 7 weeks or as an implant of radioactive seeds (brachytherapy) directly into the prostate. In external beam radiation, high energy x-rays are aimed at the tumor and the area immediately surrounding it. In brachytherapy, radioactive seeds are inserted through needles into the prostate gland under the guidance of transrectally taken ultrasound pictures. This article will describe recent advances in external beam radiotherapy [3D conformal radiotherapy (3D-CRT) & Intensity Modulated Radiotherapy (IMRT)], indications of radiotherapy, response evaluation and assessment of relapse after the radiation treatment for prostate cancer, and radiation-related complications.

Keywords: Prostate cancer; Radiotherapy; 3D-CRT; IMRT

References

1. Catalona WJ, Basler JW. Return of erections and urinary continence following nerve sparing radical retropubic prostatectomy. J Urol 1993. 150(3)905–907.
2. Eastham JA, Scardino PT. In : Walsh PC, Retik AB, Vaughan ED, et al, eds. Radical prostatectomy. Campbell's Urology 8th edth ed. Philadelphia: WB Saunders; 3080–3083.
3. Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Leibel SA, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol 2001. 166878–881.
4. Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Leibel SA, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 2000. 55(3)241–249.
5. Consensus conference. The management of clinically localized prostate cancer. JAMA 1987. 258(19)2727–2730.
6. Epstein JI, Paull G, Eggleston JC, Walsh PC. Prognosis of untreated stage A1 prostatic carcinoma: a study of 94 cases with extended followup. J Urol 1986. 136(4)837–839.
7. D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Coleman CN, et al. Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV. Int J Radiat Oncol Biol Phys 1997. 39(2)335–340.
8. Kupelian P, Katcher J, Levin H, Zippe C, Suh J, Klein E, et al. External beam radiotherapy versus radical prostatectomy for clinical stage T1-2 prostate cancer:therapeutic implications of stratification by pretreatment PSA levels and biopsy Gleason scores. Cancer J Sci Am 1997. 3(2)78–87.
9. Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Leibel SA, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer. J Clin Oncol 1999. 17(2)517–522.
10. Adolfsson J, Steineck G, Whitmore WF Jr. Recent results of management of palpable clinically localized prostate cancer. Cancer 1993. 72(2)310–322.
11. Peschel RE, Colberg JW. Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer. Lancet Oncol 2003. 4(4)233–241.
12. Catalona WJ, Smith DS. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J Urol 1994. 152(5 Pt 2)1837–1842.
13. Gibbons RP. Total prostatectomy for clinically localized prostate cancer: long-term surgical results and current morbidity. NCI Monogr 1988. (7)123–126.
14. Babaian RJ, Zagars GK, Ayala AG. Radiation therapy of stage C prostate cancer: significance of Gleason grade to survival. Semin Urol 1990. 8(4)225–231.
15. del Regato JA, Trailins AH, Pittman DD. Twenty years follow-up of patients with inoperable cancer of the prostate (stage C) treated by radiotherapy: report of a national cooperative study. Int J Radiat Oncol Biol Phys 1993. 26(2)197–201.
16. Pilepich MV, Winter K, John MJ, Mesic JB, Sause W, Grignon D, et al. Phase III radiation therapy oncology group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int J Radiat Oncol Biol Phys 2001. 50(5)1243–1252.
17. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys 1997. 37(5)1035–1041.
18. Ritter MA, Messing EM, Shanahan TG, Potts S, Chappell RJ, Kinsella TJ. Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer. J Clin Oncol 1992. 10(8)1208–1217.
19. Zagars GK, Sherman NE, Babaian RJ. Prostate-specific antigen and external beam radiation therapy in prostate cancer. Cancer 1991. 67(2)412–420.
20. Critz FA, Williams WH, Holladay CT, Levinson AK, Benton JB, Shrake PD, et al. Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques. Urology 1999. 54(6)968–971.
21. Hamilton AS, Stanford JL, Gilliland FD, Albertsen PC, Stephenson RA, Potosky AL, et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer:results from the Prostate Cancer Outcomes Study. J Clin Oncol 2001. 19(9)2517–2526.
22. Seymore CH, el-Mahdi AM, Schellhammer PF. The effect of prior transurethral resection of the prostate on post radiation urethral strictures and bladder neck contractures. Int J Radiat Oncol Biol Phys 1986. 12(9)1597–1600.

Article information Continued

Copyright © 2004 Korean Medical Association

Figure 1

Figure 1

Figure 2

Figure 2

Figure 3

Figure 3

Table 1

Table 1